A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation

A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation

In light of the favorable outcomes of few small, non-randomized clinical studies, the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to Hydroxychloroquine (HCQ) for hospitalized coronavirus disease 2019 (COVID-19) patients. In fact, subsequent clinical studies wit...

Full description

Bibliographic Details
Main Authors: Anand Prakash Singh, Sultan Tousif, Prachi Umbarkar, Hind Lal
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
Hydroxychloroquine
QT prolongation
torsades de pointes
cardiac dysfunction
pharmacovigilance analysis
arrhythmias
Online Access:https://www.mdpi.com/2077-0383/9/6/1867

Internet

https://www.mdpi.com/2077-0383/9/6/1867

Similar Items